18F-FDG PET/CT 在鉴别 IgG4 相关淋巴结病与血管免疫母细胞性 T 细胞淋巴瘤中的效用
回顾性分析 22 例 IgG4 相关淋巴结病与 22 例血管免疫母细胞性 T 细胞淋巴瘤的 18F-FDG PET/CT 表现,发现 AITL 无单一淋巴结区受累且受累淋巴结区更多;联合 SULpeak-LN/SULavg-liver、SULpeak-spleen 及受累淋巴结区数的评估方法总体分类准确率为 90.9%,18F-FDG PET/CT 有助于两者鉴别并指导活检部位选择。
要点
- AITL 患者无单一淋巴结区受累,且除颈部与盆腔淋巴结区外受累淋巴结区较 IgG4-RLAD 更多。
- 联合 SULpeak-LN/SULavg-liver、SULpeak-spleen 及受累淋巴结区数的评估方法总体分类准确率为 90.9%。
- 18F-FDG PET/CT 可帮助确定疑似 IgG4-RLAD 或 AITL 病例的最佳活检部位。
核心结论
- 18F-FDG PET/CT 是区分 AITL 与 IgG4-RLAD 的有用工具,并可帮助确定疑似病例的最佳活检部位、减少重复活检操作,使医师能够及时制定治疗策略。
研究设计与样本
- 回顾性分析临床诊断的 IgG4-RLAD 与 AITL 病例的 18F-FDG PET/CT 影像表现;最终纳入 22 例 IgG4-RLAD(17 男、5 女,中位年龄 49.5 岁)与 22 例 AITL(16 男、6 女,中位年龄 55 岁)。
关键影像表现/征象
- 记录受累淋巴结的分布、形态学特征及影像表现,以及脾脏和骨髓的 FDG 摄取。
- AITL 患者无单一淋巴结区受累。
- AITL 患者除颈部与盆腔淋巴结区外,受累的不同淋巴结区更多。
诊断标准与关键数值
- 评估以瘦体重归一化的标准化摄取值:最大值(SULmax)、平均值(SULavg)和峰值(SULpeak)。
- 采用单因素和多因素 logistic 回归筛选有统计学意义、可区分 IgG4-RLAD 与 AITL 的影像表现。
- 基于 SULpeak-LN/SULavg-liver、SULpeak-spleen 及受累淋巴结区数联合的实用评估方法,总体分类准确率为 90.9%。
临床应用与阅片要点
- 阅片时注意 AITL 无单一淋巴结区受累,且除颈部与盆腔淋巴结区外受累淋巴结区更多。
- 可结合 SULpeak-LN/SULavg-liver、SULpeak-spleen 及受累淋巴结区数进行综合评估。
- 18F-FDG PET/CT 可帮助确定疑似 IgG4-RLAD 或 AITL 病例的最佳活检部位,减少重复活检操作。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To explore the utility of the 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) positron-emission tomography (PET)/computed tomography (CT) in the differential diagnosis of IgG4-related lymphadenopathy (IgG4-RLAD) and angioimmunoblastic T-cell lymphoma (AITL).
MATERIALS AND METHODS: Retrospective analysis of 18F-FDG PET/CT imaging findings in clinically diagnosed IgG4-RLAD and AITL cases was undertaken to record the distribution, morphological characteristics, and imaging features of the affected lymph nodes, as well as FDG uptake of the spleen and bone marrow. Standardised uptake values normalised to lean body mass were evaluated for maximum (SULmax), average (SULavg), and peak values (SULpeak). Univariate and multivariate logistic regression was used to screen for statistically significant imaging findings to discriminate IgG4-RLAD from AITL.
RESULTS: Twenty-two cases of IgG4-RLAD (17 men, five women, median age 49.5 years) and 22 cases of AITL (16 men, six women, median age 55 years) were finally included in the analysis. There were no AITL patients with involvement of a single lymph node region. AITL patients had more involvement of the different nodal regions except cervical and pelvic nodal regions. A practical assessment method based on a combination of SULpeak-LN/SULavg-liver, SULpeak-spleen, and the number of involved nodal regions, improved the performance for differential diagnosis between both groups with an overall classification accuracy of 90.9%.
CONCLUSIONS: 18F-FDG PET/CT is a useful tool for distinguishing AITL from IgG4-RLAD, and it can also help determine the optimal biopsy site for suspected cases of IgG4-RLAD or AITL, reduce the need for re-biopsy procedures, and enable physicians to develop timely treatment strategies.
引用
- Chen J, Li XL, Huang M, et al. Utility of 18F-FDG PET/CT for differential diagnosis between IgG4-related lymphadenopathy and angioimmunoblastic T-cell lymphoma. Clin Radiol. 2024. PMID: 38218705. doi:10.1016/j.crad.2023.12.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。